Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Birrell C, Kell C, Ranade K, Dawson M, van der Merwe R. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. J of Skin [Internet]. 2018 Feb. 23 [cited 2024 Jul. 22];2(S1):S29. Available from: https://jofskin.org/33014/index.php/skin/article/view/281